Latest News
Nova Pangaea Technologies, which has invented a way to use non-food biomass to make biofuels and other chemicals, has raised another GBP900,000 in the run-up to a planned Series A investment later this year.
The funding comes from NPIF – Mercia Equity Finance, which is managed by Mercia and part of the Northern Powerhouse Investment Fund, the UK Government’s Future Fund and existing private investors.
The company also appointed Neil Guilder as CFO, Dr Neil Hindle as CTO and Peter McGenity as CCO in connection with the deal.
Nova Pangea Technologies completed its demonstration plant at Redcar in December 2019
- 18/08/2020
A list of 80 City investment management firms have agreed to back an initiative to increase black representation within key functions in portfolio management and finance.
The new initiative, called #100blackinterns, aims to bring together long only and hedge funds, private equity, credit and real estate managers, together with consultants and pension funds within the investment management industry, to give portfolio management function internships to young, university-educated black people.
The firms taking part in the program have committed to offer a paid internship to a black candidate next summer in a frontline investment position, and applications are welcome from black
- 17/08/2020
Jim Momtazee has launched Patient Square Capital, an investment firm that will focus on the healthcare sector. Patient Square will partner with best-in-class management teams whose products, services, and technologies improve health. The Patient Square team has a shared vision to create an investment firm capable of managing large pools of capital and with the expertise to meet the considerable and critical needs of the health care world.
Momtazee is the Managing Partner of Patient Square. He is a 21-year veteran of KKR, where he helped form its Health Care Industry Group in 2001 and subsequently led the group for over
- 17/08/2020
Agiloft has secured a USD45 million growth equity investment from FTV Capital, a sector-focused investor in innovative companies in enterprise technology and services, financial services, and payments and transaction processing. The investment from FTV is the Agiloft’s first round of external funding and will be used to build on its leadership position in the rapidly growing enterprise contract and commerce lifecycle management (CCLM) space as it accelerates its AI-based product development and expands its vertical and geographic market presence. Agiloft’s no-code platform drives industry-leading configurability and automates complex enterprise workflows through an iterative design process at a fraction of the time
- 17/08/2020
TASE UP, a new electronic platform from the Tel Aviv Stock Exchange (TASE) is aiming to link private companies seeking investment with institutional and accredited investors. Read the full story at Institutional Asset Manager…
- 17/08/2020
Lowenstein Sandler has released Getting Paid: A Look at Representations & Warranties Insurance, a new report based on a survey that, among its many goals, sought to answer a key question about reps and warranties (R&W) insurance: Do insurers actually pay claims? The answer, according to the report, is “yes” with some important caveats. Eighty-seven per cent of respondents said at least a partial payment was negotiated for all R&W claims that exceeded the self-insured retention. But more than two-thirds of respondents said that all claims fall within retention–and therefore do not result in payment by insurers.
The report was
- 17/08/2020
Inflexion has supported the expansion of its portfolio company Bollington Wilson, one of the UK’s leading independent insurance brokers, with the acquisition of Watson Laurie. The acquisition is Bollington Wilson’s fourth this year, expanding the Group’s offering and strengthening the regional presence of its operations.
Watson Laurie is a North West based corporate insurance broker specialising in Corporate Risks, Property and Construction, European Commercial Real Estate Financing, Latent Defects Insurance, SME schemes and other niches areas.
Inflexion has supported Bollington Wilson to achieve strong organic and acquisition led growth since it backed the buyout and simultaneous merger
- 17/08/2020
The Red Tree, the UK’s leading international beauty brand consultancy, and SFC Capital, a leader in the UK’s early stage investment world, have launched The Beauty Accelerator a joint initiative that will see one emerging independent beauty brand receive GBP150,000 investment plus the knowledge and expertise of The Red Tree applied over 12 months.Speaking about the launch, Stirling Murray, Managing Director of The Red Tree, says: “We are extremely excited about The Beauty Accelerator. There is an incredibly vibrant independent beauty brand scene in the UK with dynamic entrepreneurs driving game changing innovation and creating disruptive brands. We will give
- 17/08/2020
MiddleGround Capital, a private equity firm that makes control investments in North American middle market B2B industrial and specialty distribution companies, has acquired Manth-Brownell through its portfolio company Alco Manufacturing Corporation, which MiddleGround acquired in July 2018. This transaction represents MiddleGround’s fourth acquisition of 2020.
Manth-Brownell is a manufacturer of precision machined components, primarily serving the electrical connector, fluid power, industrial, appliance, safety and aerospace end markets. The company has a diverse fleet of machines, with over 100 multi-spindle screw machines and 50 CNC turning and milling machines, and operates out of a single facility in Kirkville, NY.
“The integration of
- 17/08/2020
Capsa Healthcare (Capsa), a portfolio company of Levine Leichtman Capital Partners (LLCP), has acquired NewRobo Development BV and subsidiaries (collectively, RoboPharma). Based in Waalwijk, Netherlands, RoboPharma creates and implements pharmacy automation solutions for some of the largest pharmacies in Europe.
Capsa is a leading provider of workflow products that aim to increase efficiency and reduce costs, enhance medication security, and tighten inventory control across healthcare settings worldwide. Capsa’s core offerings include mobile workstations, medication management solutions, and pharmacy automation products sold to over 3,000 end customers, including leading health systems, senior care communities, and major retail and institutional pharmacies. Capsa
- 17/08/2020
Special Reports
Featured
- Intel
- April 26, 2024
- Intel
- April 25, 2024
- Intel
- April 24, 2024
- Intel
- April 23, 2024
- Intel
- April 22, 2024
- EVENT — LONDON
- April 19, 2024
Events
16 May, 2024 – 8:30 am
16 May, 2024 – 5:30 pm
05 June, 2024 – 8:30 am
12 September, 2024 – 8:30 am
